Explore relief and management options for multiple sclerosis (MS) with Aubagio (Teriflunomide), a groundbreaking medication designed to address the specific needs of individuals living with this chronic autoimmune disorder. Dive into the distinctive features that make Aubagio a key player in the realm of MS treatment.

Key Features of Aubagio:

• Teriflunomide: The active ingredient in Aubagio, teriflunomide, belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs). It works by targeting and inhibiting specific immune cells involved in the inflammatory processes associated with MS.
• Oral Administration: Aubagio is available in an oral tablet form, offering a convenient and non-invasive method of administration. This allows for easy integration into daily routines, enhancing patient adherence to the prescribed treatment plan.
• Multiple Sclerosis Management: Aubagio is indicated for the treatment of relapsing forms of MS. By modulating the immune response, it helps reduce the frequency of relapses, slow down the progression of disability, and promote overall disease stability.
• Once-Daily Dosing: Aubagio's once-daily dosing schedule simplifies the treatment regimen, enhancing patient compliance. This regularity contributes to the medication's effectiveness in managing MS symptoms and preventing relapses.
• Neuroprotective Effects: Beyond its anti-inflammatory actions, Aubagio demonstrates neuroprotective effects, potentially preserving nerve function and integrity. This dual mechanism of action sets it apart in the landscape of MS therapeutics.

Conditions Treated with Aubagio:

Aubagio is specifically formulated for individuals diagnosed with relapsing forms of multiple sclerosis. It is designed to address the complexities of MS by:

• Reducing Relapses: Aubagio helps decrease the frequency of relapses, preventing the exacerbation of MS symptoms and promoting periods of disease stability.
• Slowing Disability Progression: By modulating the immune response, Aubagio works to slow down the progression of disability associated with MS, allowing individuals to maintain a better quality of life.
• Enhancing Neuroprotection: Aubagio's neuroprotective effects contribute to the preservation of nerve function, potentially reducing the impact of MS on the central nervous system.

Choose Aubagio for a comprehensive approach to managing relapsing forms of multiple sclerosis. With its oral convenience, once-daily dosing, and neuroprotective benefits, Aubagio stands as a vital ally in the journey towards better MS management and improved overall well-being.